Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
The Diagnosis and Staging process is the cornerstone of effective lymphoma management, providing the clinical roadmap that guides treatment decisions and predicts outcomes. Whether you are a patient newly referred for evaluation or a caregiver seeking clarity, understanding each step helps you navigate the journey with confidence. In 2023, over 80,000 new lymphoma cases were reported worldwide, underscoring the importance of precise assessment at the earliest possible moment.
At Liv Hospital, our multidisciplinary team combines state‑of‑the‑art technology with international patient support services to deliver a seamless experience from the first consultation to the final staging report. This page explains the full spectrum of diagnostic tools, imaging modalities, laboratory investigations, and the internationally recognized staging systems that together form a comprehensive picture of the disease.
By the end of this guide, you will know what tests to expect, how results are interpreted, and why accurate staging is essential for selecting the most appropriate, personalized therapy.
Lymphoma originates from malignant transformation of lymphocytes, the white blood cells that orchestrate the immune response. The two major categories are Hodgkin lymphoma (HL) and non‑Hodgkin lymphoma (NHL), each encompassing a spectrum of subtypes with distinct genetic, molecular, and clinical features.
Key biological distinctions include:
Understanding these nuances informs the selection of diagnostic markers and influences staging strategies. For instance, aggressive B‑cell lymphomas often require rapid, high‑resolution imaging and a broader panel of immunohistochemical stains, while indolent subtypes may be monitored with less intensive protocols.
At Liv Hospital, pathologists employ next‑generation sequencing and flow cytometry to delineate the molecular profile, ensuring that the subsequent diagnosis and staging steps are built on an accurate histopathological foundation.
The first phase of diagnosis and staging begins with a thorough clinical assessment, followed by tissue acquisition and basic laboratory work. This combination establishes the disease’s presence, histologic type, and initial disease burden.
Typical steps include:
In addition to these core elements, the hospital may request ancillary studies such as immunophenotyping, cytogenetics, and molecular profiling to refine the diagnosis.
These initial findings are entered into Liv Hospital’s electronic health platform, where a dedicated case manager coordinates appointments, interpreters, and travel logistics for international patients, ensuring a smooth transition to the next diagnostic phase.
Imaging provides a visual map of disease distribution, crucial for assigning a stage that reflects both the extent and the anatomical locations involved. Modern imaging modalities deliver high‑resolution data while minimizing patient discomfort.
Commonly employed techniques include:
At Liv Hospital, imaging studies are interpreted by board‑certified radiologists with expertise in oncologic imaging. The resulting reports are integrated with pathology findings, forming the basis for the next critical step: disease staging.
Beyond routine blood work, specific biomarkers enhance the precision of diagnosis and staging by reflecting tumor biology and patient prognosis. These tests are often performed concurrently with imaging to provide a comprehensive disease profile.
Important laboratory assessments include:
These biomarkers are entered into the hospital’s prognostic calculators, such as the International Prognostic Index (IPI) for NHL, which stratify patients into risk categories that directly impact staging interpretation and treatment planning.
Two internationally recognized frameworks translate diagnostic data into a stage number that guides therapy. The classic Ann Arbor system, originally designed for Hodgkin lymphoma, has been refined by the Lugano classification to incorporate modern imaging and biological insights.
Key features of each system:
Accurate staging using these systems enables the oncology team at Liv Hospital to align treatment intensity with disease extent, balancing efficacy and quality of life for each patient.
Once all diagnostic data are compiled, a tumor board comprising hematologists, radiologists, pathologists, surgeons, and supportive‑care specialists convenes to formulate a personalized treatment plan. This collaborative review ensures that every aspect of the patient’s condition—including comorbidities, performance status, and personal preferences—is considered.
The review process typically follows these steps:
Liv Hospital’s international patient services team coordinates travel, accommodation, and language assistance, allowing patients to focus on their health while the multidisciplinary team tailors the optimal therapeutic pathway.
Liv Hospital combines JCI accreditation, cutting‑edge oncology expertise, and a dedicated 360‑degree international patient program. Our multidisciplinary teams employ the latest diagnostic technologies and evidence‑based staging systems to deliver personalized care. From the moment you arrive in Istanbul, we manage appointments, transportation, interpreter services, and comfortable lodging, ensuring a seamless experience throughout your lymphoma journey.
Ready to take the next step toward precise diagnosis and effective treatment? Contact Liv Hospital today to schedule a comprehensive evaluation and benefit from our world‑class lymphoma care and international patient support.
Send us all your questions or requests, and our expert team will assist you.
The diagnostic pathway for lymphoma begins with a detailed medical history and physical examination to identify B‑symptoms and lymphadenopathy. An excisional lymph node biopsy is the preferred method to obtain tissue for histopathology, while core needle or fine‑needle aspiration may be used when surgery is not feasible. Laboratory work‑up includes a complete blood count, lactate dehydrogenase (LDH), erythrocyte sedimentation rate (ESR), and viral serologies (e.g., EBV, HIV). Ancillary studies like flow cytometry, immunophenotyping, and molecular profiling further refine the diagnosis and guide staging.
Positron Emission Tomography–Computed Tomography (PET‑CT) provides functional imaging by highlighting areas of increased glucose metabolism, which is characteristic of many lymphomas. When fused with CT anatomy, it offers precise localization of disease sites, identifies occult lesions, and assesses treatment response. Although it involves higher radiation exposure and cost, its superior sensitivity and specificity make it the preferred modality for initial staging and restaging in both Hodgkin and non‑Hodgkin lymphoma.
The Ann Arbor system, originally designed for Hodgkin lymphoma, stages disease using Roman numerals (I–IV) based on nodal involvement and the presence of systemic B‑symptoms. The Lugano classification adapts this framework for modern imaging, especially PET‑CT, introducing an “E” suffix for a single extranodal site and providing clearer criteria for bulky disease. Both systems use the same stage numbers, but Lugano offers more precise disease mapping, which influences treatment planning in contemporary practice.
At Liv Hospital, a multidisciplinary tumor board—comprising hematologists, radiologists, pathologists, surgeons, and supportive‑care specialists—convenes after all diagnostic tests are completed. The team presents clinical findings, imaging, pathology, and biomarker results, then applies prognostic indices such as IPI or FLIPI to stratify risk. Based on this comprehensive review, they discuss chemotherapy, immunotherapy, targeted agents, radiation, or stem‑cell transplantation options. International patient coordinators ensure language support and logistics, allowing patients to focus on decision‑making.
The hospital’s international patient program provides end‑to‑end assistance: visa guidance, airport transfers, hotel arrangements, and on‑site interpreter services. A dedicated case manager schedules consultations, imaging, biopsies, and follow‑up visits, entering all results into an electronic health platform accessible to the care team. This seamless coordination minimizes delays, reduces patient stress, and ensures that every diagnostic and staging step is completed efficiently, regardless of the patient’s country of origin.
BlogHematologyOct 21, 2025Rare blood cancers affect thousands of people worldwide, often with devastating consequences. Among these, ...
BlogHematologyFeb 18, 2026Rare hematological diseases affect a small part of the population. This makes finding and treating them har...
BlogHematologyOct 21, 2025At Liv Hospital, we know how scary a diagnosis about the lymphatic system can be. Many fear that a swollen ...
BlogHematologyOct 21, 2025It’s important to know the latest on diagnosis and treatment for blood malignancies. At Liv Hospital,...
BlogHematologyOct 21, 2025Blood cancers affect the blood, bone marrow, and lymphatic system. They impact thousands of people globally...
BlogHematologyOct 21, 2025We are dedicated to helping patients and families grasp the complex world of blood cancers. At LivHospital,...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 71 24
